Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Pyrazines/pharmacology"'
Autor:
Odile Burlet-Schiltz, Bernard Monsarrat, Stéphane Manenti, Marie-Pierre Bousquet-Dubouch, Mariette Matondo, Christian Recher, Sandrine Uttenweiler-Joseph, Bernard Payrastre, Nathalie Gallay
Publikováno v:
Leukemia Research
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩
International audience; The proteasome plays a critical role in the regulation of many cellular processes, including the cell cycle and tumor growth. The proteasome inhibitor bortezomib has recently been approved for the treatment of relapsed and ref
Autor:
Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll, Matthew L Albert
Publikováno v:
Nature Immunology
Nature Immunology, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
Nature Immunology, Nature Publishing Group, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
Nature Immunology, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
Nature Immunology, Nature Publishing Group, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
International audience; The success of antitumor immune responses depends on the infiltration of solid tumors by effector T cells, a process guided by chemokines. Here we show that in vivo post-translational processing of chemokines by dipeptidylpept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e2ab8828a29afd88e17c54fdc280cd
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380810
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380810